{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T03:09:36Z","timestamp":1783739376148,"version":"3.55.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020483","name":"Insmed Incorporated","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.rmed.2025.108406","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:48:25Z","timestamp":1760060905000},"page":"108406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Persistent use of amikacin liposome inhalation suspension associated with lower risk of hospitalizations and emergency room visits in refractory Mycobacterium avium complex lung disease"],"prefix":"10.1016","volume":"249","author":[{"given":"Kevin L.","family":"Winthrop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Waweru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5656-8469","authenticated-orcid":false,"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leona E.","family":"Markson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2025.108406_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ccm.2014.10.002","article-title":"Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review","volume":"36","author":"Prevots","year":"2015","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.rmed.2025.108406_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.rmed.2017.03.010","article-title":"Impact of cavity and infiltration on pulmonary function and health-related quality of life in pulmonary","volume":"126","author":"Asakura","year":"2017","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2025.108406_bib3","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/j.rmed.2011.08.004","article-title":"Impaired health-related quality of life in pulmonary nontuberculous mycobacterial disease","volume":"105","author":"Mehta","year":"2011","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2025.108406_bib4","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1080\/17476348.2021.1987891","article-title":"Nontuberculous mycobacterial lung disease caused","volume":"15","author":"van Ingen","year":"2021","journal-title":"Expet Rev. Respir. Med."},{"key":"10.1016\/j.rmed.2025.108406_bib5","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02109-2016","article-title":"Burden of non-tuberculous mycobacterial pulmonary disease in Germany","volume":"49","author":"Diel","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108406_bib6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.rmed.2018.10.022","article-title":"Relative risk of all-cause mortality in patients with nontuberculous mycobacterial lung disease in a US managed care population","volume":"145","author":"Marras","year":"2018","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2025.108406_bib7","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00535-2020","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"56","author":"Daley","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108406_bib8","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.chest.2018.01.024","article-title":"Microbiologic outcome of interventions against","volume":"153","author":"Diel","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2025.108406_bib9","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1164\/rccm.201807-1318OC","article-title":"Amikacin liposome inhalation suspension for treatment-refractory lung disease caused by Mycobacterium avium complex (CONVERT). A prospective, open-label, randomized study","volume":"198","author":"Griffith","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2025.108406_bib11","doi-asserted-by":"crossref","first-page":"e1408","DOI":"10.1093\/cid\/ciac394","volume":"76","author":"Ku","year":"2023","journal-title":"Evaluat. Clin. Infect. Dis."},{"key":"10.1016\/j.rmed.2025.108406_bib13","article-title":"Multicollinearity in regression analyses conducted in epidemiologic studies","volume":"6","author":"Vatcheva","year":"2016","journal-title":"Epidemiology"},{"key":"10.1016\/j.rmed.2025.108406_bib14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1186\/s12890-022-02257-8","article-title":"Impact of initiation of amikacin liposome inhalation suspension on hospitalizations and other healthcare resource utilization measures: a retrospective cohort study in real-world settings","volume":"22","author":"Aksamit","year":"2022","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.rmed.2025.108406_bib16","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12890-023-02460-1","article-title":"Real-world treatment patterns in patients with nontuberculous mycobacterial lung disease in the Netherlands based on medication dispensing data","volume":"23","author":"Hoefsloot","year":"2023","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.rmed.2025.108406_bib17","article-title":"Retrospective analysis to assess the effect of targeted clinical interventions on the discontinuation rate of amikacin liposome inhalation suspension therapy among patients treated for refractory Mycobacterium avium complex lung disease","volume":"205","author":"Hebble","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2025.108406_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s41030-024-00263-1","article-title":"Qualitative interviews exploring adverse event mitigation strategies in adults receiving amikacin liposome inhalation suspension","volume":"10","author":"Ali","year":"2024","journal-title":"Pulm Ther."},{"key":"10.1016\/j.rmed.2025.108406_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa079","article-title":"Clinical management of respiratory adverse events associated with amikacin liposome inhalation suspension: results from a patient survey","volume":"7","author":"Swenson","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.rmed.2025.108406_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad500.1693","article-title":"Refractory nontuberculous mycobacterial pulmonary disease: natural history and burden of illness in patients from the US bronchiectasis and NTM research registry (BRR)","volume":"10","author":"Aksamit","year":"2023","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.rmed.2025.108406_bib22","first-page":"A768","volume":"vol. 164","author":"Winthrop","year":"2023"},{"key":"10.1016\/j.rmed.2025.108406_bib23","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1128\/AAC.02281-12","article-title":"Treatment of refractory Mycobacterium avium complex lung disease with a moxifloxacin-containing regimen","volume":"57","author":"Koh","year":"2013","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095461112500469X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095461112500469X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T02:04:30Z","timestamp":1763690670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095461112500469X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":19,"alternative-id":["S095461112500469X"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108406","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistent use of amikacin liposome inhalation suspension associated with lower risk of hospitalizations and emergency room visits in refractory Mycobacterium avium complex lung disease","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108406","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108406"}}